NEWSpublisher 2007 :: AngloChinese Investments
SEARCH NEWS
date from:
date to:
company:
search for string:
NEWS SECTIONS
COMPANY GROUPS
TOP NEWS
» 23/07/2009 [Company watch]
China Aoxing Pharmaceutical Corp. Receives Renewal of GMP Certification for Capsule Dosage Form of Pharmaceutical Products
» 15/03/2010 [Industry news]
Recordati S.p.A And Lee Pharmaceutical Announce Partnership For Zanidip(R) In China
» 26/10/2009 [Finance]
China Growth to Remain Fast in Fourth Quarter, Official Says
» 17/08/2009 [Industry news]
Chindex Posts Profit on Product Sales, Health Services
» 07/05/2010 [Industry news]
Hong Kong: Recall of all products manufactured by Quality Pharmaceutical Lab Ltd
COMPANY NEWS » Independent reports back to previous page show list
»27/05/2008 [Independent reports]
Ernst & Young reports record deals, smaller losses for biotech industry

Ernst & Young has released its annual report, Beyond Borders: Global Biotechnology Report 2008, which notes record high levels of venture capital in 2007 at $7.5 billion in the U.S. and $60 billion in new deals. In addition, globally the industry moved closer to profitability as it pruned its losses from $7.4 billion in 2006 to $2.7 billion in 2007. In the United States, according to the report, biotech came closer to overall profitability as an industry than in any previous year. The report mentions potential for changes in current trends, including a push for personalized medicine that will affect the current drug market; pharma companies collaborating with biotech firms; and companies embracing globalization by working with other markets. In Europe, the biotech industry's revenue decreased, while products awaiting clinical trial increased. Australia and China saw an increase in IPOs worth $750 million.

 

AngloChinese Investments ltd.
Home | Company news | TOP 50 | Events | About us
C&F Bright Solutions ltd.